SECdecoded Read filings, not jargon.

CVS HEALTH Corp FY 2025 10-K, explained in plain English

CVS · 10-K for the period ending December 31, 2025, filed February 10, 2026 · Read the original on SEC.gov →

Key financials — as reported

Total revenue$402.1B
Gross margin45.0%
Operating income$4.7B
Net income$1.8B
Diluted EPS$1.39
Cash & equivalents$8.5B
Total assets$253.5B
Long-term debt$60.5B

Key takeaway

CVS reported $402.1 billion in revenue but only $1.77 billion in net income, indicating significant cost or expense pressure eating into margins.

🔒 4 more takeaways in the full analysis

Beneath the surface

The effective tax rate reconciliation includes unusual offsetting items—a -83.9% impact from a business disposition and +56.3% from nondeductible impairment losses—suggesting one-time events materially distorted the tax rate and possibly net income, masking underlying operating performance.

🔒 3 more insights a headline reader would miss

This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for CVS.

Read the full analysis free Free account · 5 full analyses included · no card required